The resources on this webpage cover a variety of drug-related issues, including information on drug use, emergency room data, prevention and treatment programs, and other research findings. Syringe-services programs, which provide clean injection equipment to people who inject drugs, are highly effective harm-reduction measures, greatly reducing the spread of infectious disease. The euphoria wears off quickly, leading to a “crash.” Some people try to avoid this and extend the euphoria by repeatedly taking the drug in a binge pattern. Repeated use in this way increases the risk of developing a methamphetamine use disorder. Buprenorphine treatment can also be started in the emergency department to ease withdrawal and cravings after an overdose.13 This can help motivate people to begin long-term treatment.
Why do so few people get medications for opioid use disorder?
For those who do develop OUD or other SUDs, effective treatments are critical to reduce their risk of overdose. HEAL research strives to develop new or improved prevention and treatment strategies for OUD and other SUDs, including PolySUD. These interventions must be tailored to the severity of one’s overall risk and the range of settings in which they can be deployed.
Reported use of most drugs among adolescents remained low in 2024
NIDA explores in this video the intriguing similarities between the processes of brain development and computer… NIDA Director Dr. Nora Volkow explains why we study teen drug use and shares a message to parents & teen influencers. Although it also binds to the mu-opioid receptor, naltrexone blocks the receptor, rather than activates it.
- (1) Advance research to prevent and treat OUD and overdoses including from polysubstance use disorders.
- A person is diagnosed with opioid use disorder if they have two or more of the symptoms and behaviors related to their opioid use listed in the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.
- Methamphetamine is a powerful lab-made (synthetic) stimulant with high addiction potential.1 The U.S. Food and Drug Administration (FDA) has approved methamphetamine for treatment of attention deficit hyperactivity disorder (ADHD) as well as for short-term treatment of obesity.
- Research also suggests that drug checking approaches, such as fentanyl test strips, can help people understand what is in their drug supply before use.
- Drug combinations also complicate the treatment of OUD and other SUDs, as the severe physical withdrawal from drugs like fentanyl and xylazine render MOUD harder to implement.
Medications to treat opioid use disorder
Treatment with methadone or buprenorphine is recommended for pregnant women with opioid use disorder. Buprenorphine treatment may lead to better health outcomes for infants than methadone treatment. For example, infants whose mothers were treated with buprenorphine were less likely to have neonatal opioid withdrawal syndrome or have a low birth weight than those whose mothers were treated with methadone.36 NIDA-funded studies are investigating the best approach for treating opioid use disorder in pregnant women. For example, they may use opioid drugs more or for longer than intended, experience a strong desire to use opioid drugs (cravings), continue to use opioid drugs even when knowing that it causes problems, or experience withdrawal symptoms when stopping opioid use.1 To learn more, see the NIDA research topic about addiction science.
- Research is needed to develop interventions to prevent and treat polysubstance use and related overdoses.
- Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
- When a person suddenly stops taking their medication abruptly, they may experience withdrawal symptoms.
- Department of Health and Human Services, community organizations, research institutions, and the private sector.
Research also suggests that drug checking approaches, such as fentanyl test strips, can help people understand what is in their drug supply before use. Scientific research has established that pharmacological treatment of opioid use disorder increases retention in treatment programs and decreases drug use, infectious disease transmission, and criminal activity. Methamphetamine is also present in many people who die from overdoses involving fentanyl. (1) Advance research to prevent and treat OUD and overdoses including from polysubstance use disorders. The emergency and referral resources listed above are available to individuals located in the United States and are not operated by the National Institute on Drug Abuse (NIDA). NIDA is a biomedical research organization and does not provide personalized medical advice, treatment, counseling, or legal consultation.
What are the harms of methamphetamine use during pregnancy?
A variety of effective treatments are available for heroin use disorder, including both behavioral and pharmacological (medications). Both approaches help to restore a degree of normalcy to brain function and behavior, resulting in increased employment rates and lower risk of HIV and other diseases and criminal behavior. Although behavioral and pharmacologic treatments can be extremely useful when utilized alone, research shows that for many people, integrating both types of treatments is the most effective approach.
Approaches such as contingency management and cognitive-behavioral therapy have been shown to effectively treat heroin use disorder, especially when applied in concert with medications. Contingency management uses a voucher-based system in which patients earn “points” based on negative drug tests, which they can exchange for items that encourage healthy living. Cognitive-behavioral therapy is designed to help modify the patient’s expectations and behaviors related to drug use and to increase skills in coping with various life stressors. An important task is to match the best treatment approach to meet the particular needs of the patient. When people addicted to opioids like heroin first quit, they undergo withdrawal symptoms (pain, diarrhea, nausea, and vomiting), which may be severe.
Where can people get methadone treatment?
Buprenorphine is another opioid medication that is used to treat opioid use disorder. Buprenorphine also binds to and activates mu-opioid receptors in the brain, but to a lesser degree than methadone; it also can block other opioid drugs from attaching to those receptors. Like methadone, buprenorphine can reduce cravings and withdrawal symptoms without producing intense feelings of pleasure and intoxication in people who have opioid use disorder. Both methadone and buprenorphine bind to and activate the same mu-opioid receptors in the brain as do other opioid drugs. However, when taken as prescribed by people with opioid use disorder, methadone and buprenorphine prevent drug cravings and withdrawal symptoms without causing the intense feelings of pleasure (or “high”) that other opioid drugs produce. Managing OUD and co-occurring conditions can be especially challenging for healthcare providers.
Information provided by NIDA is not a substitute for professional medical care or legal consultation. Opioid use disorder is a complex, treatable chronic medical condition from which people can recover. A person is diagnosed with opioid use disorder if they have two or more of the symptoms and behaviors related to their opioid use listed in the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. There are many interrelated factors between chronic pain and substance use disorders.
Find the latest science-based information about drug use, health, and the developing brain. Designed for young people and those who influence them—parents, guardians, teachers, and other educators—these resources inspire learning and encourage critical thinking so teens can make informed decisions about drug use and their health. Information provided by NIDA is not a substitute for professional medical care. However, diagnosing and treating co-occurring substance use and other mental disorders is complex, because people may have overlapping symptoms.
NIDA has led more than half of this work, with an investment of $2.1 billion in 1,200 research projects since the inception of HEAL. When a person suddenly stops taking their medication abruptly, they may experience withdrawal symptoms. However, these effects are milder than those what are the treatments for heroin use disorder national institute on drug abuse nida produced by dependence on other opioid drugs and can be managed by slowly reducing the medication dose rather than stopping it abruptly. The many effective behavioral treatments available for opioid use disorder can be delivered in outpatient and residential settings.
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov. Since its launch with the support of Congress in 2018, the NIH HEAL Initiative has made the nation’s largest ever investment in research to end the national overdose crisis.